NCT01627561 2020-04-10
Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old
GlaxoSmithKline
Phase 3 Completed
Clinical Trials
3 trialsNCT00001575 2015-12-07
Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00019227 2013-06-20
Monoclonal Antibody Therapy in Treating Patients With Leukemia
National Cancer Institute (NCI)
Phase 1/2 Completed